Business Wire Feed
Ironfist Therapeutics’ 177Lu-Tamrada™ Doubles Survival with Anti-PD-1 Therapy in Checkpoint-Resistant Pancreatic Cancer Model
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Ironfist Therapeutics (“Ironfist”), a preclinical-stage company developing a nanomedicine radiopharmaceutical (Tamrada) that selectively targets tumor-associated macrophages without a targeting ligand, will present positive preclinical proof-of-concept results for 177Lu-Tamrada at the 39th Annual more...
Debiopharm’s Pre-Clinical Proof-Of-Concept Research Unveils the Potential of Novel MultiLINK Linker Technology to Overcome Tumor Resistance
LAUSANNE, Switzerland--(BUSINESS WIRE)-- #ADC--Debiopharm (www.debiopharm.com), a privately-owned, Swiss-based biopharmaceutical company aiming to establish tomorrow’s standards of care to cure cancer and infectious diseases, today announced their latest research on antibody drug conjugate (ADC) research released more...
Takeda Presents Phase 2/3 IgGNITE Study Results of Investigational Subcutaneous TAK-881 in Primary Immunodeficiency Disease (PID) at ESID 2026
OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda presents Phase 2/3 study results for TAK-881 in primary immunodeficiency (PID), showing comparability to HYQVIA with 50% less IG volume.
Altay Therapeutics Closes $37 Million Series A Financing to Advance First Oral DUX4 Inhibitor for FSHD into the Clinic
SAN CARLOS, Calif.--(BUSINESS WIRE)--Altay Therapeutics Closes $37 Million Series A Financing to Advance First Oral DUX4 Inhibitor for FSHD into the Clinic
SelectQuote to Release Fiscal First Quarter 2027 Earnings on November 4
OVERLAND PARK, Kan.--(BUSINESS WIRE)--SelectQuote, Inc. (NYSE: SLQT), a leading distributor of Medicare insurance policies and owner of a rapidly growing healthcare services platform, today announced it will release its first quarter 2027 financial results before more...
Akamis Bio Completes Enrollment of the Phase 1b FORTRESS Study of NG-350A in Mismatch Repair-Proficient Locally Advanced Rectal Cancer
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Akamis Bio, a clinical-stage oncology company working to advance the standard of care in colorectal cancer, today announced that it has completed enrollment of the Phase 1b FORTRESS study of NG-350A, an oncolytic more...
Coya to Initiate Open-Label Extension of Phase 2/3 ALSTARS Trial of COYA 302 in ALS
HOUSTON--(BUSINESS WIRE)--Coya Therapeutics, Inc. (NASDAQ: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company developing biologics intended to enhance T-cell (Treg) function in patients with neurodegenerative disorders, today announced plans to initiate an open-label extension more...
Fortune Media and Great Place To Work Name Maxim Healthcare to 2026 Best Workplaces in Health Care List, Ranking No. 17
COLUMBIA, Md.--(BUSINESS WIRE)--Great Place To Work® and Fortune magazine have named Maxim Healthcare to the 2026 Fortune Best Workplaces in Health Care™ List.
MindWalk Holdings Corp. Strengthens Boston-Based Development Leadership as Pipeline Advances Toward Preclinical Efficacy Studies
BOSTON--(BUSINESS WIRE)---- $HYFT #ai--MindWalk Holdings Corp. (NASDAQ: HYFT) (“MindWalk” or the “Company”), a Bio-Native AI company, today announced three senior appointments that strengthen its Boston-based development leadership as the Company’s pipeline advances toward preclinical efficacy more...
Beacon Hospital Research Institute and B-Secur Launch Pilot to Bring ECG Data from Consumer Wearables Directly into Clinical Care
DUBLIN--(BUSINESS WIRE)-- #CardiovascularHealth--B-Secur and Beacon Hospital Research Institute launch clinical pilot to bring ECG data from any consumer wearable directly into the clinical workflow.
Galderma Signs Agreement to Acquire ZO Skin Health, Strengthening Its Physician-Dispensed Skincare Offering
ZUG, Switzerland & IRVINE, Calif.--(BUSINESS WIRE)--Galderma (SIX: GALD) today announced that it has signed an agreement to acquire ZO® Skin Health, a leading physician-dispensed skincare brand built on clinical science and protocol-based daily care, from more...
Alentis and PinotBio Announce Collaboration to Develop Next-Generation ADCs Targeting claudin-1
BASEL, Switzerland & SUWON, South Korea--(BUSINESS WIRE)--Under the agreement, Alentis and PinotBio will discover and develop next-generation antibody-drug conjugates targeting claudin-1 for oncology.
Otometrics Launches Aurical® IQ – Delivering the First and Only Guided Workflow Enabling up to 51% Faster Fittings and 39% Improved Workflow Accuracy
HOFFMAN ESTATES, Ill.--(BUSINESS WIRE)--Otometrics, the Hearing & Balance division of Natus Sensory, today announced Aurical® IQ, the next generation of its trusted hearing aid fitting and verification platform. Combining the first and only Guided Workflow more...
OneAdvanced Leverages NVIDIA Technologies to Advance Safer Agentic AI for UK Critical Sectors
BIRMINGHAM, England--(BUSINESS WIRE)--We are excited to be extending our work with NVIDIA to help advance the safe and trusted deployment of agentic AI. This builds upon our launch in June this year of Care Navigator, more...
Quantori Named a Major Contender in Everest Group’s Pharmaceutical R&D IT Services PEAK Matrix® Assessment 2026
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- #ArtificialIntelligence--Quantori has been named a Major Contender in Everest Group’s Pharmaceutical R&D IT Services PEAK Matrix® Assessment 2026
Brellium Raises $23M, Debuts CortexLM to Fix Gaps in Care and Compliance Before They Cost Providers
NEW YORK--(BUSINESS WIRE)--Brellium raises $23M and debuts CortexLM, an AI system that audits clinical notes. It has protected nearly $2B in provider revenue from clawbacks.
Acadia Healthcare Announces Date for Third Quarter 2026 Earnings Release
FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that it will release its third quarter 2026 results on Wednesday, November 4, 2026, after the close of the market. Acadia will host a conference more...
OpenEvidence and Johns Hopkins Medicine Announce Landmark Collaboration to Design the Future of Medicine and Medical Education in the Age of AI
MIAMI & BALTIMORE--(BUSINESS WIRE)-- #ClinicalAI--OpenEvidence and Johns Hopkins Medicine are collaborating to design medical education and clinical care for the AI era, with patients at the center.
Flatiron Health Expands Telescope to International Real-World Data, Bringing AI-Powered Oncology Insights to a Global Database of More Than Six Million Patients
NEW YORK--(BUSINESS WIRE)--Flatiron Health today announced the international expansion of Flatiron Telescope, its AI-powered oncology intelligence platform, extending its capabilities to datasets from the UK, Germany, and Japan. Building on Telescope’s launch earlier this year, more...
Comprehensive Cancer Centers of Nevada Makes DeepScribe Ambient AI Part of Care at Its 13 Locations
SAN FRANCISCO--(BUSINESS WIRE)--DeepScribe, the ambient AI leader for oncology, announced today that Comprehensive Cancer Centers of Nevada (CCCN), one of the region's largest and most trusted community oncology groups, has deployed DeepScribe's Ambient Operating System more...
GC Biopharma to Present Expanded IVIG Aggregation Analysis and Additional Phase 3 ALYGLO® Safety Analysis at IgNS 2026
TEANECK, N.J.--(BUSINESS WIRE)--GC Biopharma to Present Expanded IVIG Aggregation Analysis and Additional Phase 3 ALYGLO® Safety Analysis at IgNS 2026
Alight Introduces GLP-1 HRA Solution to Help Employers Manage Access, Affordability and Cost
DEERFIELD, Ill.--(BUSINESS WIRE)--Alight, Inc. (NYSE: ALIT), a leading benefits administration provider of health, wealth and leave solutions, today announced a new health reimbursement account (HRA) that helps employers offer financial support to their employees for more...
Plexus Worldwide Joins Personalized Nutrition Initiative at the University of Illinois Urbana-Champaign as a New External Partner
SCOTTSDALE, Ariz.--(BUSINESS WIRE)-- #drrenhaulai--Global leader in gut health, Plexus Worldwide, has joined the external partners program in the Personalized Nutrition Initiative at the National Center for Supercomputing Applications, University of Illinois Urbana-Champaign (U of I). more...
Evolution Fresh Launches Thrive, a New Line of Light and Refreshing Functional Juices
RANCHO CUCAMONGA, Calif.--(BUSINESS WIRE)-- #beverages--Evolution Fresh, a leading producer of organic, cold-pressed, premium juice products, today announced the launch of Thrive, a new line of light, refreshing functional juices designed for everyday wellness, now available more...
Avanza + MedHQ Acquires Fulcrum Strategies, Adding Dedicated Payer Contracting Capabilities
WESTCHESTER, Ill.--(BUSINESS WIRE)--Avanza + MedHQ, a leading provider of advisory, management, and administrative solutions to hospitals and health systems, ambulatory surgery centers (ASCs), outpatient care providers, and physicians throughout the United States, has acquired Fulcrum more...